Fibromyalgia in Psoriatic Arthritis Associated With Poor Quality of Life
Researchers evaluated the association between fibromyalgia in psoriatic arthritis and enthesopathy, sleep, fatigue, and quality of life.
Researchers evaluated the association between fibromyalgia in psoriatic arthritis and enthesopathy, sleep, fatigue, and quality of life.
Researchers evaluated the frequency and severity of pain and fatigue in patients with psoriatic arthritis receiving tumor necrosis factor inhibitors.
Simple Fibromyalgia Assessment Screening Tool indices may facilitate the diagnosis of fibromyalgia in the routine care of patients with other rheumatic diseases.
The prevalence of neuropathic-like pain was found to be high in patients with psoriatic arthritis, a condition that may be associated with higher disease activity and fibromyalgia.
Inflammation, disease duration, and chronic pain were identified as the main factors underlying fatigue experienced by patients with psoriatic arthritis.
The PALACE 4 trial found that apremilast monotherapy improved symptoms and was generally well-tolerated in DMARD-naive psoriatic arthritis.
Underlying synovitis and enthesitis may go undetected in clinical findings, but can be detected by power Doppler ultrasounds.
Etanercept therapy reduces clinical markers of disease activity in patients with psoriatic arthritis while stabilizing cardiovascular disease risk factors over a period of 5 years.
Serum amyloid A levels were found to significantly correlate with C-reactive protein levels in psoriatic arthritis.
Ixekizumab benefits patients with treatment-resistant psoriatic arthritis when administered over a 2- or 4-week period.